Methoden vergleichen

	COSMIN: Bewertung der methodischen Qualität von Studien zu Messinstrumenten	Cochrane Risk of Bias Tool 2.0 für randomisierte kontrollierte Studien
Fachgebiet	Forschungsmethodik	Forschungsmethodik
Familie	Process / pipeline	Process / pipeline
Entstehungsjahr	2010	2019
Urheber	Mokkink et al. (COSMIN Group)	Jonathan Sterne, Julian Higgins (Cochrane Collaboration)
Typ	Measurement instrument evaluation	Clinician-rated / Research team assessment
Wegweisende Quelle	Mokkink, L. B., Terwee, C. B., Patrick, D. L., Alonso, J., Stratford, P. W., Knol, D. L., ... & de Vet, H. C. (2010). The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Quality of Life Research, 19(4), 539–549.	Sterne, J. A., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., ... & Higgins, J. P. (2019). RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ, 366, l4898.
Aliasnamen	COSMIN	RoB 2.0, RoB 2
Verwandt	4	4
Zusammenfassung	COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments) is a systematic framework and 10-item checklist developed by Mokkink et al. (2010) to evaluate the methodological quality of studies that assess the measurement properties of patient-reported outcome measures (PROMs), questionnaires, and clinical scales. COSMIN guides the development, validation, and selection of health measurement instruments across clinical research and practice.	RoB 2 is the Cochrane Collaboration's updated methodology for assessing the risk of bias in randomized controlled trials (RCTs). Published in 2019, it replaced the original Cochrane RoB tool with a more structured, transparent approach using signalling questions and domain-based judgments to evaluate five critical sources of bias.